# Chemotherapy_Induced_Neutropenia_Pharmacogenomics
This study aims to investigate pharmacokinetic and pharmacodynamic genetic variants using both candidate-gene and genome-wide association approaches to predict the risk of chemotherapy-induced neutropenia.
